← MACROGENICS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $91.9m |
$157.7m
+71.68%
|
$60.1m
-61.89%
|
$64.2m
+6.76%
|
$104.9m
+63.40%
|
$77.4m
-26.16%
|
$151.9m
+96.19%
|
$58.7m
-61.33%
|
$150.0m
+155.26%
|
$149.5m
-0.31%
|
$157.1m
+5.07%
|
|
| Cost of Revenue | $122.1m |
$147.2m
+20.59%
|
$190.8m
+29.61%
|
$0
-100.00%
|
$0 | $2.7m |
$3.4m
+26.41%
|
$619k
-81.53%
|
$847k
+36.83%
|
$0
-100.00%
|
$40.1m | |
| Gross Profit (Calculated) (derived) | ($30.2m) |
$10.5m
+134.79%
|
($130.7m)
-1343.63%
|
$64.2m
+149.11%
|
$104.9m
+63.40%
|
$74.8m
-28.69%
|
$148.6m
+98.66%
|
$58.1m
-60.88%
|
$149.1m
+156.52%
|
$149.5m
+0.26%
|
— | |
| Research and Development Expense | $122.1m | $147.2m | $190.8m | $195.3m | $193.2m | $214.6m | $207.0m | $166.6m | $177.2m | $147.2m | $142.4m | |
| General and Administrative Expense | $29.8m | $32.7m | $40.5m | $46.1m | $42.7m | $63.0m | $58.9m | $52.2m | $71.0m | $39.2m | — | |
| Operating expenses: | ||||||||||||
| Operating Income (Loss) | ($60.0m) |
($22.1m)
+63.12%
|
($171.2m)
-673.18%
|
($177.2m)
-3.49%
|
($131.1m)
+26.03%
|
($202.8m)
-54.73%
|
($121.4m)
+40.13%
|
($168.2m)
-38.57%
|
($110.6m)
+34.28%
|
($72.8m)
+34.13%
|
($63.7m)
+12.61%
|
|
| Interest Expense | — | — | — | — | — | — | — | $1.4m | $1.1m | — | $13.3m | |
| Interest Income, Other | — | $2.4m | $2.3m | $3.4m | $800k | $2.0m | $1.7m | $4.0m | $5.6m | $3.4m | $5.9m | |
| Other Nonoperating Income (Expense) | $1.5m | $2.5m | ($247k) | $25.4m | $1.3m | $680k | $1.7m | $9.7m | $9.4m | $6.1m | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | — | $8.5m | $13.3m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | — | — | — | $119.8m | $9.1m | ($66.0m) | ($75.3m) | ($71.0m) | |
| Income Tax Expense (Benefit) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $944k | ($672k) | ($672k) | |
| Net Income (Loss) Attributable to Parent | ($58.5m) |
($19.6m)
+66.47%
|
($171.5m)
-773.60%
|
($151.8m)
+11.46%
|
($129.7m)
+14.54%
|
($202.1m)
-55.79%
|
($119.8m)
+40.75%
|
($9.1m)
+92.44%
|
($67.0m)
-639.30%
|
($74.6m)
-11.43%
|
($70.4m)
+5.71%
|
|
| Earnings Per Share, Basic | ($1.69) | ($0.54) | ($4.19) | ($3.16) | ($2.47) | ($3.37) | ($1.95) | ($0.15) | ($1.07) | ($1.18) | ($1.11) | |
| Earnings Per Share, Diluted | ($1.69) | ($0.54) | ($4.19) | ($3.16) | ($2.47) | ($3.37) | ($1.95) | ($0.15) | ($1.07) | ($1.18) | ($1.11) | |
| Income (Loss) from Continuing Operations, Per Basic Share | ($2) | ($1) | ($4) | ($3) | ($2) | ($3) | ($2) | ($0) | ($1) | ($1) | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | ($2) | ($1) | ($4) | ($3) | ($2) | ($3) | ($2) | ($0) | ($1) | ($1) | — | |
| Weighted Average Number of Shares Outstanding, Basic | 34.7m | 36.1m | — | 48.1m | 52.4m | 59.9m | 61.4m | 61.9m | 62.6m | 63.2m | 63.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | 34.7m | 36.1m | — | 48.1m | 52.4m | 59.9m | 61.4m | 61.9m | 62.6m | 63.2m | 63.3m | |
| Additional Financial Items | ||||||||||||
| Costs and Expenses | $151.9m | $179.9m | $231.3m | $241.4m | $235.9m | $280.2m | $273.4m | $227.0m | $260.5m | $222.3m | — |